ArticlePloS one2023

The VIPR2-selective antagonist KS-133 changes macrophage polarization and exerts potent anti-tumor effects as a single agent and in combination with an anti-PD-1 antibody.

Kotaro Sakamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.